# The Efficacy and Safety of Topical Vitamin D Drop on Meibomian Gland Function in Patients With Meibomian Gland Dysfunction

> **NCT05495958** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 56 (estimated)

## Conditions studied

- Meibomian Gland Dysfunction

## Interventions

- **DRUG:** Topical Vitamin D eye drop
- **DRUG:** Topical placebo eye drop

## Key facts

- **NCT ID:** NCT05495958
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-25
- **Primary completion:** 2022-10-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2022-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05495958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05495958, "The Efficacy and Safety of Topical Vitamin D Drop on Meibomian Gland Function in Patients With Meibomian Gland Dysfunction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05495958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*